We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
Cap. Flow
-$277M
Cap. Flow %
-4.05%
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$127M
2
ANAB icon
AnaptysBio
ANAB
+$76M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$62.1M
4
TSM icon
TSMC
TSM
+$59.5M
5
LKQ icon
LKQ Corp
LKQ
+$45.9M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$89.2M
2
CNC icon
Centene
CNC
+$80.2M
3
HOLX
Hologic
HOLX
+$75.2M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$65.8M
5
BAX icon
Baxter International
BAX
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 49.61%
2 Technology 13.09%
3 Communication Services 5.22%
4 Consumer Discretionary 2.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
76
Fate Therapeutics
FATE
$286M
$24.5M 0.36%
+1,501,258
New +$17.8M
SNNA
77
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$23.4M 0.34%
1,576,311
+25,018
+2% +$398K
WMGI
78
DELISTED
Wright Medical Group Inc
WMGI
$23.3M 0.34%
+804,187
New +$21.7M
EA icon
79
Electronic Arts
EA
$53B
$22.5M 0.33%
186,604
-104,497
-36% -$13.5M
IRTC icon
80
iRhythm Holdings
IRTC
$3.85B
$22.3M 0.33%
235,941
-254,489
-52% -$22.2M
CLVS
81
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$22M 0.32%
750,200
-34,500
-4% -$1.34M
CME icon
82
CME Group
CME
$96.3B
$21.3M 0.31%
124,918
-37
-0% -$6.23K
EBAY icon
83
eBay
EBAY
$50.6B
$21M 0.31%
+636,024
New +$22M
SRPT icon
84
Sarepta Therapeutics
SRPT
$1.57B
$19.8M 0.29%
+122,490
New +$16.7M
KURA icon
85
Kura Oncology
KURA
$800M
$19.3M 0.28%
1,103,656
+16,533
+2% +$317K
ALNA
86
DELISTED
Allena Pharmaceuticals
ALNA
$19M 0.28%
1,768,568
+28,763
+2% +$316K
CI icon
87
Cigna
CI
$73.8B
$18.2M 0.27%
+87,351
New +$16.2M
MRNS
88
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$17.7M 0.26%
+443,524
New +$12.6M
ARAY icon
89
Accuray
ARAY
$32M
$17.7M 0.26%
3,925,756
-1,124,814
-22% -$4.43M
PVTL
90
DELISTED
Pivotal Software, Inc.
PVTL
$16.8M 0.25%
855,797
-123,426
-13% -$3.01M
GRUB
91
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$15.3M 0.22%
+55,218
New +$14.2M
GRTS
92
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$14.3M 0.21%
+1,065,313
New +$15.2M
ELGX
93
DELISTED
Endologix Inc
ELGX
$14.2M 0.21%
740,859
-13,357
-2% -$477K
UBX
94
DELISTED
Unity Biotechnology
UBX
$12.6M 0.18%
82,987
+352
+0.4% +$58K
RCUS icon
95
Arcus Biosciences
RCUS
$3.55B
$10.1M 0.15%
723,834
-44,445
-6% -$567K
IVTY
96
DELISTED
Invuity, Inc
IVTY
$10.1M 0.15%
1,360,334
– –
NCNA
97
NuCana
NCNA
$5.49M
$9.7M 0.14%
78
-6
-7% -$707K
VRAY
98
DELISTED
ViewRay, Inc.
VRAY
$8.23M 0.12%
+879,446
New +$8.64M
TECX
99
Tectonic Therapeutic
TECX
$529M
$7.73M 0.11%
+12,412
New +$5.5M
NTGN
100
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$7.34M 0.11%
978,837
+4,076
+0.4% +$45.2K
2 3
4
5 6

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2018 Portfolio in Review

As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.

  • PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
  • PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
  • PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
  • PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
  • PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
  • PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.